
### [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633)
**Label:** Osteosarcoma by AJCC v7 Stage

**Subclasses:** [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 52.17%
- [CL:0000062](http://purl.obolibrary.org/obo/CL_0000062) (osteoblast) 52.17%
- [NCIT:C36900](http://purl.obolibrary.org/obo/NCIT_C36900) (Neoplastic Osteoblast) 39.70%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 37.53%
- [NCIT:C36901](http://purl.obolibrary.org/obo/NCIT_C36901) (Malignant Osteoblast) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 37.53%


